TV News LIES

Wednesday, Jul 26th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Trump administration ends funding for teen pregnancy programs

Trump ends funding for teen pregnancyA nationwide, successful teen pregnancy prevention program is being eliminated under President Donald Trump's proposed FY...

Europe’s Populists Want to Make Polio Great Again

Beppe GrilloDiseases rarely seen in modern society are popping back up in Italy and elsewhere in Europe,...

Tobacco companies interfere with health regulations, WHO reports

Tobacco companies interfere with health regulations: WHOCigarette manufacturers are attempting to thwart government tobacco controls wherever possible, even as governments make progress...

New GOP plan to repeal Obamacare meets fatal opposition

Mitch McConnelSenate Republicans' Plan B to gut Obamacare is poised for failure, as three GOP senators said...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!